A randomized, controlled, open label non-inferiority trial of intravenous ferric carboxymaltose versus iron sucrose in patients with iron deficiency anemia in China.

Autor: Jin, Jie, Ran, Zhihua, Noseda, Emanuele, Roubert, Bernard, Marty, Matthieu, Mezzacasa, Anna, Göring, Udo Michael

Publikováno v: Frontiers of Medicine; Feb2024, Vol. 18 Issue 1, p98-108, 11p

Comparison of Secukinumab and Adalimumab Monotherapy as First-line Biologic Therapy in Patients with Active Psoriatic Arthritis: Proposed Design of a Randomized, Double-blind, Active Control, Multicenter Study

Autor: Mpofu, Shephard, McInnes, Iain, Ding, Kevin, Noseda, Emanuele, Pricop, Luminita

Publikováno v: 44. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh); 30. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh); 26. Jahrestagung der Gesellschaft für Kinder-und Jugendrheumatologie (GKJR); 20160831-20160903; Frankfurt am Main; DOCSP.26 /20160829/

Background: Latest guidelines highlight the importance of biologics in the management of PsA, with TNF-inhibitors being the most widely used [ref:1]. Secukinumab is an interleukin-17A inhibitor approved forthe treatment of PsA. Head-to-head trials ar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c20be36c78f52c2f98e62856265d9782

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.